Nevertheless, those promising results rely on high systemic concentrations of AuNPs [13,14,15], or the further modification of AuNPs with targeting moieties such as thioglucose [16,17], HER-2 (human epidermal growth factor receptor-2) [18], or goserelin [19] depending on specific tumor types. This evidence concerns the gene ERBB2 and neoplasm.